CHO Pharma, Inc. (TPEX:6586)
54.30
-6.70 (-10.98%)
Apr 17, 2026, 1:59 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 11.56 billion as of April 17, 2026. Its market cap has decreased by -3.23% in one year.
Market Cap
11.56B
Enterprise Value
9.35B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.30
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 11.56B, a decrease of -22.95%. That is a compound annual growth rate of -3.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 11.56B | 92.17% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.59B |
| Ever Supreme Bio Technology | 12.26B |
| Tanvex BioPharma | 10.78B |
| Locus Cell | 10.22B |